This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_GALLBLADDER_EXALLC for full statistics.
Malignant neoplasm of gallbladder
C3_GALLBLADDER
gallbladder neoplasm: A neoplasm (disease) that involves the gall bladder.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
156 |
4. Check minimum number of eventsNone |
156 |
5. Include endpointsNone |
156 |
6. Filter based on genotype QC (FinnGen only) |
156 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of gallbladder
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder
- Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 156 | 97 | 59 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | 72.06 | 72.46 | 71.40 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 138
- Matched controls
- 1378
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C23
ICD-10 Finland
Malignant neoplasm of gallbladder
8818.7
160.3
122
*
8140/3-C23.9
ICD-O-3
Adenocarcinoma, NOS, of gallbladder
+∞
107.9
89
*
130
Kela drug reimbursment
Malignant tumour
17.6
39.5
68
72
8000/3-C23.9
ICD-O-3
Neoplasm, malignant of gallbladder
+∞
24.7
23
*
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
23.2
72
185
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
17.6
22.0
35
26
UJK02
NOMESCO Finland
ERCP
26.6
20.5
28
13
L01BC06
ATC
capecitabine; oral
16.3
20.2
33
26
A04AA02
ATC
granisetron; systemic, transdermal
11.8
19.8
38
43
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
26.3
19.0
26
12
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
39.0
18.6
23
7
K83.0
ICD-10 Finland
Cholangitis
61.4
18.5
21
*
H02AB02
ATC
dexamethasone; systemic
8.3
18.1
43
71
JKA20
NOMESCO Finland
Cholecystectomy
13.4
17.6
31
29
Z51.5
ICD-10 Finland
Palliative care
10.5
17.4
35
43
N02AA05
ATC
oxycodone; systemic
5.8
17.3
58
153
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
8.0
16.9
41
69
WX302
NOMESCO Finland
Thoracal epidural anesthesy
10.9
16.4
32
37
JJB30
NOMESCO Finland
Excision of two segments of liver
179.5
15.8
16
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
18.1
15.0
23
15
K83.1
ICD-10 Finland
Obstruction of bile duct
48.1
14.5
17
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
34.1
14.3
18
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
7.5
13.2
32
53
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
6.3
13.0
37
76
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
27.4
12.8
17
7
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
41.7
12.5
15
*
JN4CD
NOMESCO Finland
Very extensive body CT
10.4
11.8
23
26
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
130.4
11.6
12
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
10.5
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.0
10.1
21
27
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
39.5
9.2
11
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
7.3
8.9
21
33
JN4BD
NOMESCO Finland
Extensive body CT
4.6
8.9
32
85
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
53.5
8.8
10
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.8
8.5
24
48
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
11.9
8.5
15
14
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
11.1
8.3
15
15
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
26.7
7.7
10
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.1
7.6
24
55
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
7.6
55
252
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
84.4
7.5
8
*
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
7.4
7
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.0
7.3
30
90
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
11.8
6.9
12
11
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
6.7
50
229
K82.9
ICD-10 Finland
Disease of gallbladder, unspecified
73.1
6.5
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.9
6.4
20
46
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
28.1
6.3
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
8.3
6.3
13
17
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
38
13
38.32
58.66
3.6
1.2
u/ml
4.3
287.5
0.47
38
13
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
44
119
4.76
15.67
4.0
2.3
g/l
0.2
0.2
1.27
44
107
(3002256) Pathology report gross observation
41
145
3.48
9.73
1.5
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
33
103
3.80
9.41
7.0
6.2
mmol/l
5.8
10.3
5.15
33
93
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
18
7.79
8.99
1.8
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
86
532
2.37
6.53
10.7
10.5
inr
1.2
1.3
0.19
27
152
(40768441) Liver Pathology biopsy report
10
8
13.24
6.17
1.3
1.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
65
369
2.31
5.88
6.7
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
97
652
2.29
5.82
26.1
6.2
umol/l
23.5
11.4
1.57
97
611
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
117
2.82
5.34
7.3
2.6
u/l
31.2
30.5
0.08
29
93
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
80
1079
0.47
5.08
4.4
5.1
mmol/l
5.9
6.1
0.70
74
966
(3033658) Prothrombin time (PT) actual/Normal
53
291
2.24
5.07
10.4
3.7
%
84.8
85.5
0.08
53
285
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
78
1060
0.47
5.03
5.0
6.4
mmol/mol
40.1
41.3
0.44
66
973
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
78
1054
0.48
4.82
5.0
4.8
mmol/l
4.8
4.5
0.87
66
955
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
78
1048
0.49
4.61
4.7
4.7
mmol/l
1.5
1.5
0.04
67
937
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
83
1091
0.49
4.57
4.9
5.4
mmol/l
2.7
2.6
0.31
69
978
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
50
279
2.17
4.53
2.7
2.3
—
—
—
0
0
(4035726)
28
122
2.58
4.42
1.4
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
80
540
1.99
4.28
5.5
4.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
34
3.74
3.85
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
46
266
2.03
3.72
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
19
75
2.75
3.62
4.9
8.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
60
386
1.90
3.55
3.1
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
78
1008
0.55
3.37
4.4
4.3
mmol/l
1.3
1.2
0.13
68
896
(3017143) Hepatitis C virus Ab [Presence] in Serum
20
87
2.49
3.16
1.5
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
101
1204
0.54
3.13
50.0
24.3
pg
30.4
30.3
0.08
101
1179
(3000963) Hemoglobin [Mass/volume] in Blood
101
1204
0.54
3.13
50.4
24.6
g/l
122.1
132.4
9.02
101
1177
(3024731) MCV [Entitic volume]
101
1203
0.54
3.09
50.3
24.3
fl
92.0
91.6
0.31
101
1178
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
88
2.46
3.09
1.5
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
80
1011
0.57
2.95
4.3
5.0
mu/l
2.0
2.0
0.10
72
889
(3020682) Albumin/Creatinine [Ratio] in Urine
21
397
0.46
2.90
3.1
3.9
mg/mmol
3.2
6.5
—
7
244
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
6
8.55
2.77
3.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
97
1147
0.59
2.47
33.8
15.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
53
362
1.70
2.42
3.7
5.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
99
1160
0.60
2.35
43.1
20.2
umol/l
71.4
79.7
3.77
99
1160
(3042936) Bacteria identified in Isolate by Culture
31
182
1.88
2.34
1.8
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
17
323
0.47
2.33
2.4
3.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
365
0.51
2.20
2.3
3.0
mg/l
6107.4
211.9
—
7
235
(3023183) Ammonium ion [Moles/volume] in Plasma
8
25
3.32
2.12
1.9
3.2
umol/l
54.3
26.4
—
8
18
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
87
1041
0.63
2.11
32.9
16.0
ml/min/173m2
80.1
72.6
2.97
80
853
(3002385) Erythrocyte distribution width [Ratio]
73
908
0.63
2.11
42.5
20.7
%
14.7
14.0
2.85
73
887
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
37
540
0.59
2.10
2.0
2.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
15
4.11
2.06
1.3
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
101
1166
0.62
2.05
31.1
11.1
u/l
34.5
23.6
5.85
101
1112
(3013707) Erythrocyte sedimentation rate by Westergren method
70
869
0.65
1.92
4.2
4.4
mm/h
23.6
14.8
2.39
65
774
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
67
835
0.65
1.83
3.5
4.0
pmol/l
15.4
15.1
0.32
61
737
(3022948) Iron [Moles/volume] in Serum or Plasma
30
193
1.69
1.67
2.7
2.4
umol/l
14.4
12.8
0.48
30
171
(3018418) pH of Serum or Plasma
54
403
1.52
1.64
3.5
4.0
ph
7.4
7.4
0.69
13
80
(3004789) Transferrin [Mass/volume] in Serum or Plasma
28
179
1.69
1.60
2.5
2.3
g/l
2.3
2.3
0.07
28
160
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
20
3.08
1.59
1.2
3.6
%
60.0
65.5
—
6
20
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
7
27
2.67
1.53
2.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
75
892
0.69
1.45
46.1
22.7
g/l
330.9
330.6
0.09
75
884
(3019060) Gas panel - Arterial blood
17
97
1.84
1.41
3.9
4.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
17
98
1.82
1.37
5.8
4.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
40
290
1.51
1.37
15.2
7.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
83
960
0.71
1.29
33.3
18.2
%
36.3
38.6
1.64
52
623
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10
185
0.51
1.25
2.2
3.0
ug/l
1.0
0.7
—
5
123
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
76
632
1.39
1.24
6.1
6.5
mmol/l
1.2
1.2
2.00
64
532
(3024354) Oxygen [Partial pressure] in Venous blood
5
110
0.44
1.18
2.8
2.6
kpa
3.9
4.0
—
5
104
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
20
2.55
1.16
1.6
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
20
2.55
1.16
1.2
2.6
e9/l
2.8
5.5
—
5
20
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
36
0.00
1.15
0.0
4.4
—
33.8
—
0
25
(3048689) Calprotectin [Mass/mass] in Stool
19
120
1.66
1.15
2.5
1.9
ug/g
372.4
154.0
0.39
19
94
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
31
2.32
1.12
1.3
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
31
2.32
1.12
1.3
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
24
164
1.55
1.07
4.6
6.9
mmol/l
1.5
1.7
0.11
18
135
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
30
0.00
0.98
0.0
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
16
101
1.65
0.98
2.1
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
29
212
1.45
0.95
1.7
1.8
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.11
0.90
1.2
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
29
2.11
0.90
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
10
56
1.84
0.90
1.6
1.6
ug/l
1.2
5.4
—
10
51
(40768804) Tissue Pathology biopsy report
57
473
1.32
0.88
3.3
2.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
46
1.78
0.84
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
0
24
0.00
0.80
0.0
3.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
24
0.00
0.80
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
24
0.00
0.80
0.0
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
0
24
0.00
0.80
0.0
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
25
0.00
0.80
0.0
1.3
—
4.1
—
0
5
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
26
0.00
0.79
0.0
1.3
—
1.5
—
0
5
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
26
0.00
0.79
0.0
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
23
303
0.72
0.72
5.1
5.1
ug/l
1.9
2.4
0.53
18
268
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
43
515
0.77
0.71
1.9
2.1
pmol/l
91.8
95.1
0.22
29
237
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
129
1.45
0.67
4.9
4.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
5
30
1.69
0.62
1.4
4.9
—
—
—
0
0
(3044889) 12 lead EKG panel
75
832
0.81
0.62
4.7
4.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
72
1.57
0.61
2.9
2.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
23
0.00
0.59
0.0
1.5
—
—
—
0
0
(3000492) Spirometry study
5
87
0.56
0.58
2.0
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
42
493
0.80
0.58
21.5
10.4
e9/l
0.0
0.0
0.72
37
406
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
100
923
1.23
0.58
28.1
7.4
u/l
152.3
78.8
5.60
100
846
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
151
1.37
0.57
1.6
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
65
1.58
0.57
2.1
1.5
g/l
0.9
1.2
—
10
56
(3019225) pH of Specimen
15
108
1.43
0.55
2.6
3.9
—
—
—
0
0
(3015736) pH of Urine
40
469
0.80
0.54
4.7
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
244
1.28
0.53
4.2
5.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
12
83
1.48
0.53
2.8
3.1
g/l
10.7
10.0
0.23
12
75
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
154
1.34
0.51
1.6
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
45
1.58
0.49
1.6
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
30
249
1.25
0.46
4.4
4.1
ng/l
117.3
132.4
0.07
21
213
(1616796) Gas panel - Central venous blood
5
31
1.63
0.43
1.8
2.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
22
177
1.28
0.43
6.6
6.2
mmol/l
104.8
103.8
0.58
22
171
(3019230) Fractional oxyhemoglobin in Venous blood
0
15
0.00
0.41
0.0
2.2
—
60.4
—
0
15
(3039443) Prostate specific Ag panel - Serum or Plasma
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
15
0.00
0.41
0.0
1.3
—
215.0
—
0
15
(40768800) Prostate Pathology biopsy report
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
16
0.00
0.41
0.0
1.3
—
31.0
—
0
16
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
66
1.39
0.39
1.0
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
12
157
0.74
0.38
1.3
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
41
1.48
0.36
1.5
1.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
61
556
1.16
0.36
6.2
5.4
e9/l
0.6
0.6
0.11
56
481
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
21
252
0.81
0.35
1.5
1.7
mg/l
1.1
1.4
0.26
14
204
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
15
118
1.30
0.35
4.3
4.3
mmol/l
1.2
1.2
0.11
15
104
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
6
44
1.38
0.35
1.5
4.1
mg/l
20.7
26.2
—
6
34
(3034860) Kappa light chains.free [Mass/volume] in Serum
6
44
1.38
0.35
1.5
4.1
mg/l
23.9
223.9
—
6
34
(3019198) Lymphocytes [#/volume] in Blood
62
567
1.16
0.35
6.2
5.4
e9/l
1.5
1.8
2.09
56
504
(3022217) INR in Platelet poor plasma by Coagulation assay
23
192
1.23
0.34
18.3
25.1
inr
1.2
1.3
—
8
23
(3022145) Colonoscopy Study observation
10
132
0.74
0.33
2.0
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
38
335
1.18
0.33
2.6
3.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
131
0.75
0.32
2.9
2.6
ug/l
1.7
6.7
—
10
114
(3006315) Basophils [#/volume] in Blood
61
560
1.15
0.32
6.1
5.4
e9/l
0.0
0.0
0.50
55
486
(3021601) Nitrite [Presence] in Urine by Test strip
54
589
0.87
0.31
5.4
5.8
estimate
0.0
0.0
0.00
17
104
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
247
0.83
0.29
3.5
4.2
%
24.9
21.0
—
9
119
(3035350) Ketones [Presence] in Urine by Test strip
55
596
0.88
0.28
4.7
4.3
estimate
0.0
0.0
0.00
18
108
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
8
66
1.22
0.27
4.9
7.6
mmol/l
24.1
25.3
—
8
66
(3013115) Eosinophils [#/volume] in Blood
62
576
1.13
0.27
6.3
5.6
e9/l
0.2
0.2
0.40
57
507
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
56
517
1.13
0.26
3.7
4.1
ng/l
53.8
34.4
0.22
47
399
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
75
0.66
0.26
2.0
1.4
—
—
—
0
0
(4010399)
5
75
0.66
0.26
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
18
212
0.83
0.26
2.2
2.8
e6/l
1.2
1.0
0.14
11
124
(3019150) Specific gravity of Urine by Refractometry
24
275
0.85
0.26
5.3
4.9
kg/l
1.0
1.0
—
7
44
(3029937) Albumin [Presence] in Urine by Test strip
37
333
1.15
0.25
5.6
4.8
estimate
0.0
0.0
0.00
16
105
(3018095) Leukocytes [#/volume] in Urine
41
450
0.88
0.25
2.6
4.0
e6/l
105.2
112.2
0.05
34
324
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
34
305
1.15
0.24
2.5
2.2
mg/l
2.9
3.2
0.49
34
268
(40761535) Cells panel - Urine sediment
14
115
1.24
0.24
3.3
3.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
12.8
—
0
10
(3016879) Cocaine [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
17
197
0.85
0.21
2.3
3.1
e6/l
5.9
3.3
—
10
110
(3009261) Glucose [Presence] in Urine by Test strip
56
597
0.90
0.21
4.8
4.4
estimate
0.0
0.0
0.00
17
103
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(4281824)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
100
1.22
0.18
2.4
1.8
nmol/l
403.2
397.0
0.04
12
91
(3007164) IgA [Mass/volume] in Serum or Plasma
18
205
0.86
0.18
1.7
1.4
g/l
2.0
2.7
1.13
13
118
(3004588) Protein electrophoresis panel - Serum or Plasma
12
101
1.20
0.17
2.0
2.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
286
0.89
0.16
4.2
4.1
—
—
—
0
0
(3012544) pH of Venous blood
11
130
0.83
0.16
2.5
3.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
150
0.85
0.15
15.2
7.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
83
800
1.08
0.15
6.4
5.4
—
3436.2
—
0
18
(3022621) pH of Urine by Test strip
7
90
0.77
0.15
4.3
3.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
12
103
1.18
0.14
1.1
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
10
113
0.88
0.08
2.1
2.6
g/l
65.7
65.3
—
10
100
(3021879) Hepatitis B virus core Ab [Presence] in Serum
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
15
164
0.91
0.08
1.5
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
8
76
1.06
0.07
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
14
128
1.10
0.07
1.6
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
16
148
1.09
0.06
2.4
3.2
%
2.1
1.8
0.72
16
133
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
119
1.10
0.06
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
331
0.96
0.04
4.6
4.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
44
451
0.97
0.03
3.4
3.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
30
292
1.03
0.02
1.2
1.9
pmol/l
489.8
483.5
0.05
24
239
(3014111) Lactate [Moles/volume] in Serum or Plasma
11
117
0.94
0.02
4.5
6.7
mmol/l
3.0
1.3
0.43
11
112
(3000991) Gas panel - Venous blood
11
104
1.06
0.01
4.5
8.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
20
194
1.04
0.00
1.5
1.7
s
31.7
29.5
0.74
20
186
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
10
96
1.04
0.00
4.7
3.5
ml/min/173m2
64.0
55.4
—
5
39
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
13
131
0.99
0.00
1.5
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
46
459
1.00
0.00
3.0
3.3
—
—
—
0
0
(3013512) EKG study
37
375
0.98
0.00
3.1
4.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
472
0.99
0.00
5.1
4.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
81
806
1.01
0.00
5.4
5.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
81
0.99
0.00
1.4
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
4.4
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
19.6
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020891) Body temperature
5
56
0.89
0.00
3.4
3.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
59
1.02
0.00
1.2
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
52.8
—
0
5
(3016018) Differential panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
8
79
1.01
0.00
3.1
2.8
kpa
4.8
5.1
—
8
72
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
33.6
—
0
7
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
734.2
—
0
5
(4027681)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
4.2
2.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.2
—
57.0
—
0
5
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
9
0.00
0.00
0.0
22.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
7
0.00
0.00
0.0
2.7
—
11.1
—
0
7
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
69
0.86
0.00
6.3
9.6
mmol/l
23.7
25.0
—
6
64
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
6.7
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GALLBLADDER – Malignant neoplasm of gallbladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).